LifeStance Health Group/LFST

$5.64

-1.91%
-
1D1W1MYTD1YMAX

About LifeStance Health Group

LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

Ticker

LFST

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Kenneth Burdick

Employees

6,866

Headquarters

Scottsdale, United States

LFST Metrics

BasicAdvanced
$2.2B
Market cap
-
P/E ratio
-$0.47
EPS
-
Beta
-
Dividend rate
$2.2B
$9.59
$4.74
1.6M
1.177
19.585
19.79
-4.69%
-8.12%
-11.8%
-8.93%
1.975
1.524
21.39%
11.03%
40.92%

What the Analysts think about LFST

Analyst Ratings

Majority rating from 8 analysts.
Hold

Price Targets

Average projection from 7 analysts.
55.85% upside
High $10.00
Low $8.00
$5.64
Current price
$8.79
Average price target

LFST Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-6.99% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$300M
7.06%
Net income
-$21M
-53.23%
Profit margin
-6.99%
-56.31%

LFST Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 34.07%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.13
-$0.17
-$0.12
-$0.06
-
Expected
-$0.09
-$0.08
-$0.09
-$0.09
-$0.06
Surprise
50%
112.5%
29.23%
-34.07%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for LifeStance Health Group stock?

LifeStance Health Group (LFST) has a market cap of $2.2B as of May 29, 2024.

What is the P/E ratio for LifeStance Health Group stock?

The price to earnings (P/E) ratio for LifeStance Health Group (LFST) stock is 0 as of May 29, 2024.

Does LifeStance Health Group stock pay dividends?

No, LifeStance Health Group (LFST) stock does not pay dividends to its shareholders as of May 29, 2024.

When is the next LifeStance Health Group dividend payment date?

LifeStance Health Group (LFST) stock does not pay dividends to its shareholders.

What is the beta indicator for LifeStance Health Group?

LifeStance Health Group (LFST) does not currently have a Beta indicator.

What is the LifeStance Health Group stock price target?

The target price for LifeStance Health Group (LFST) stock is $8.79, which is 55.85% above the current price of $5.64. This is an average based on projections from 7 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell LifeStance Health Group stock

Buy or sell LifeStance Health Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing